Falcon Genomics, Inc. is a biotech that provides genomic solutions for the accurate diagnosis of cancer patients and prediction of efficient and targeted therapy. Falcon Genomics is currently marketing two services: a gene expression profiling service using the Affymetrix GeneAtlas System, and Falcon Genomics’ patented Cancer BioChip System (CBCS) which consists of a siRNA-based kit for the identification of inhibitors of tumor growth in 3D.